Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all
Allogene Therapeutics's competitors and similar companies include Adaptimmune.
 Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. |  Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. | |
Founding Date | Founding Date 2018 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB |
Employees | Employees 2263% decrease | Employees 4007% decrease |
Valuation ($) | Valuation ($) 585.5 m | Valuation ($) 188.5 m |
Financial | ||
Net income | Net income ($190.9m) (FY, 2025) | Net income ($70.8m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 532m | Total funding raised $ 107.5m |
For sources of this data, please see the company profile
View Company Profiles
Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
View company